Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ATRC
ATRC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ATRC News
DAFNA Capital Management Reduces Stake in Biotechnology ETF
Mar 21 2026
NASDAQ.COM
DAFNA Capital Management Reduces Stake in iShares Biotechnology ETF
Mar 21 2026
Fool
AtriCure Chief Scientific Officer Sells 5,000 Shares Amid Negative Returns
Mar 18 2026
Fool
ATRICURE INC: UBS Lowers Price Target to $55 from $60
Feb 18 2026
moomoo
Wall Street Analysts Adjust Ratings
Feb 18 2026
Benzinga
AtriCure Reports Strong Q4 2025 Earnings with 15% Revenue Growth
Feb 18 2026
seekingalpha
AtriCure Q4 Earnings Exceed Expectations
Feb 17 2026
seekingalpha
AtriCure Shares Plunge After JPMorgan Downgrade
Feb 11 2026
seekingalpha
Elekta EKTAY's Evo CT-Linac Receives FDA Clearance, Enhancing Personalized Radiation Therapy
Jan 19 2026
NASDAQ.COM
DexCom Reports Q4 2025 Revenue of $1.26 Billion, Up 13%
Jan 16 2026
NASDAQ.COM
VentriPoint Diagnostics Secures $1 Million Funding to Propel AI Medical Imaging Growth
Jan 16 2026
Globenewswire
AtriCure Inc (ATRC) Releases 2025 Product Pipeline Analysis Report
Jan 01 2026
Businesswire
AtriCure (ATRC) Sees a 6.32% Increase Over the Past Week: Key Information to Consider
Dec 19 2025
NASDAQ.COM
Wall Street Analysts Predict AtriCure (ATRC) May Surge 36.3%: Here's How to Invest
Nov 25 2025
NASDAQ.COM
Key Metrics Insights on AtriCure's (ATRC) Revised Q3 Earnings
Nov 06 2025
NASDAQ.COM
Fascinating ATRC Put and Call Options Set for December 19th
Oct 28 2025
NASDAQ.COM
Show More News
